APR Pharma
ActiveSummary
APR Pharma has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93,506 and a net result of €39,279. Equity is shrinking by ~46.6% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 40% of 50 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 5 accounts on average 8 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
History
Go further with this company
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.3% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €24,686 | €25,000 | €25,000 | €27,135 | €30,694 | ▲ 13.1% |
| Other operating charges640/8 | €695 | €348 | €384 | €387 | €661 | ▲ 70.6% |
| Gross operating margin9900 | -€216,483 | -€172,247 | -€2,511 | -€667 | €70,657 | ▲ 10,690% |
| Operating profit (loss)9901 | -€241,864 | -€197,594 | -€27,896 | -€28,190 | €39,303 | ▲ 239% |
| Financial income75/76B | - | - | - | - | €6 | - |
| Recurring financial income75 | - | - | - | - | €6 | - |
| Financial charges65/66B | €139 | €30 | €30 | €30 | €30 | = |
| Recurring financial charges65 | €139 | €30 | €30 | €30 | €30 | = |
| Profit (loss) for the period before taxes9903 | -€242,003 | -€197,624 | -€27,926 | -€28,220 | €39,279 | ▲ 239% |
| Profit (loss) for the period9904 | -€242,003 | -€197,624 | -€27,926 | -€28,220 | €39,279 | ▲ 239% |
| Profit (loss) for the period to be appropriated9905 | -€242,003 | -€197,624 | -€27,926 | -€28,220 | €39,279 | ▲ 239% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €394,310 | €309,780 | €239,168 | €263,063 | €244,955 | ▼ 6.9% |
| Fixed assets21/28 | €225,314 | €200,314 | €175,314 | €196,883 | €178,768 | ▼ 9.2% |
| Intangible fixed assets21 | €225,314 | €200,314 | €175,314 | €196,883 | €178,768 | ▼ 9.2% |
| Current assets29/58 | €168,996 | €109,466 | €63,853 | €66,180 | €66,187 | = |
| Stocks and contracts in progress3 | - | - | - | - | €10,900 | - |
| Stocks30/36 | - | - | - | - | €10,900 | - |
| Amounts receivable within one year40/41 | €5,626 | €9,000 | €34,578 | €1,160 | €8,839 | ▲ 662% |
| Trade receivables40 | - | €6,764 | €34,578 | €647 | €5,217 | ▲ 707% |
| Other amounts receivable41 | €5,626 | €2,235 | - | €513 | €3,621 | ▲ 606% |
| Cash at bank and in hand54/58 | €163,371 | €100,466 | €29,276 | €65,020 | €46,448 | ▼ 28.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €394,310 | €309,780 | €239,168 | €263,063 | €244,955 | ▼ 6.9% |
| Equity10/15 | €257,997 | €60,373 | €32,447 | €4,227 | €93,506 | ▲ 2,112% |
| Contributions10/11 | €500,000 | €500,000 | €500,000 | €500,000 | €55,000 | ▼ 89.0% |
| Profit (loss) carried forward14 | -€242,003 | -€439,627 | -€467,553 | -€495,773 | €38,506 | ▲ 108% |
| Amounts payable17/49 | €136,314 | €249,407 | €206,721 | €258,836 | €151,449 | ▼ 41.5% |
| Amounts payable within one year42/48 | €136,314 | €249,407 | €206,721 | €258,836 | €151,449 | ▼ 41.5% |
| Trade debts44 | €32,444 | €145,538 | €97,394 | €118,147 | €16,432 | ▼ 86.1% |
| Suppliers440/4 | €32,444 | €145,538 | €97,394 | €118,147 | €16,432 | ▼ 86.1% |
| Taxes, remuneration and social security45 | - | - | €5,457 | - | - | - |
| Taxes450/3 | - | - | €5,457 | - | - | - |
| Other amounts payable47/48 | €103,870 | €103,870 | €103,870 | €140,688 | €135,017 | ▼ 4.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€242,003 | -€197,624 | -€27,926 | -€28,220 | €39,279 | ▲ 239% |
| + Depreciation and write-downs630 | €24,686 | €25,000 | €25,000 | €27,135 | €30,694 | ▲ 13.1% |
| Operating cash flow (approximation) | -€217,317 | -€172,624 | -€2,926 | -€1,085 | €69,973 | ▲ 6,552% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€48,704 | -€12,579 | ▲ 74.2% |
| Change in cash | - | -€62,904 | -€71,191 | €35,744 | -€18,572 | ▼ 152% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52322A0090/00T000 | Wallonia | 1.2 ha | 1 · 4,355 m² | 8.8 m · 3 fl. |
Linked by address, not proof of ownership
Structure & network
Owners and holdings
1 ownerOwners 1
-
10%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Food safety, FASFC
1 siteSimilar companies · same sector, comparable size
Identification & contact
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.